FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 9.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,518,000 | -46.5% | 1,776,613 | -7.9% | 0.17% | -50.9% |
| Q3 2021 | $6,575,000 | -65.8% | 1,928,157 | -18.3% | 0.34% | -60.2% |
| Q2 2021 | $19,244,000 | -33.7% | 2,361,229 | 0.0% | 0.85% | -28.8% |
| Q1 2021 | $29,043,000 | -32.6% | 2,361,229 | 0.0% | 1.20% | -35.1% |
| Q4 2020 | $43,116,000 | +315.3% | 2,361,229 | +255.1% | 1.85% | +258.8% |
| Q3 2020 | $10,381,000 | – | 665,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |